Reissue Patent
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/docs/US/2024-04-02/USRE49893E1/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
-
Application No.: US17584155Application Date: 2022-01-25
-
Publication No.: USRE49893E1Publication Date: 2024-04-02
- Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Hague , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Priority: IN 1611022328 2016.06.29
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/437 ; A61K31/4427 ; A61K45/06 ; C07D249/00 ; C07D471/04
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/abs-image/US/2024/04/02/USRE49893E1/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Information query
